{'Year': '2018', 'Month': 'Jul', 'Day': '01'}
Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.
Metformin, an oral hypoglycemic drug is the first line of treatment for Type 2 diabetes individuals. We studied the effect of critical gene single nucleotide polymorphismsÂ  on the glucose lowering effect of metformin.